Article

Consensus-Derived Risk Stratification to Guide Surveillance in Primary Uveal Melanoma: The PRIME Delphi Study

2026-06-14

Abstract excerpt

<title>Abstract</title> <p> <bold>Background</bold> Primary uveal melanoma (PUM) carries a substantial risk of metastatic progression yet, approaches to risk stratification and surveillance vary widely across Brazilian centers. The PRIME Delphi study ( <italic>Individual Risk-Based Prognosis in Primary Uveal Melanoma study</italic> ) aimed to define expert consensus on prognostic determinants and surveillance...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 3d9179a9-d3d0-5707-a9a9-41483f962fda
DOI: 10.21203/rs.3.rs-9450293/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Consensus-Derived Risk Stratification to Guide Surveillance in Primary Uveal Melanoma: The PRIME Delphi StudyDOI 10.21203/rs.3.rs-9450293/v1Read

Development of a Metastatic Uveal Melanoma Prognostic risk Score (MUMPS) for use in patients receiving immune checkpoint inhibitorsSemantic proximity Read

French updated recommendations in Stage I to III melanoma treatment and management.Semantic proximity Read

European consensus-based interdisciplinary guideline for melanoma. Part 2: Treatment - Update 2022.Semantic proximity Read

Multiple primary melanomas (MPMs) and criteria for genetic assessment: MultiMEL, a multicenter study of the Italian Melanoma IntergroupSemantic proximity Read

Enhancing prognostication in uveal melanomaSemantic proximity Read

Using risk factors for detection and prognostication of uveal melanoma.Semantic proximity Read

Mapping Research Trends of Uveal Melanoma: A Bibliometric AnalysisSemantic proximity Read

Malignant melanoma: evolving practice management in an era of increasingly effective systemic therapies.Semantic proximity Read

Recommended first-line management of brain metastases from melanoma: A multicenter survey of clinical practice.Semantic proximity Read

Long-term survival after neoadjuvant low-dose ipilimumab plus high-dose nivolumab in resectable stage III melanoma: the 5-year survival-update and biomarker analysis from the PRADO-trialSemantic proximity Read

Consensus Guideline for the Management of Patients with Peritoneal MesotheliomaSemantic proximity Read

Head and neck mucosal melanoma: radiological considerations and UK imaging guidelinesSemantic proximity Read